CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing an advanced cell culture system called Multidyn to enhance the discovery of biomarkers for diabetes. By utilizing a low-cost, multi-chamber design, it aims to improve in-vitro testing methods that better mimic human physiology, thereby aiding early drug development processes.
Biomarkers in discovery are valuable tools to understand the pathobiology of a disease and the pharmacology of a target under investigation.
In-vitro screen would be invaluable in identifying working hypothesis early in drug development process.
Information provided by properly selected biomarkers can greatly influence a go/no go decision.
The challenge is to identify relevant biomarkers early enough to implement them for such critical decisions.In developing in-vitro assays to identify biomarke…
IVTECH SRL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Finland, TAMPERE
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Germany, BERNRIED
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
